Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A randomized phase II study of sapacitabine, an oral nucleoside analogue, in elderly patients with AML previously untreated or in first relapse or previously treated MDS 45th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) Garcia-Manero, G., Luger, S., Venugopal, P., Maness, L., Wetzler, M., Coutre, S., Stock, W., Borthakur, G., Chiao, J., Kantarjian, H. AMER SOC CLINICAL ONCOLOGY. 2009
View details for Web of Science ID 000276606605012